Pneumonia: all 2,072 studies

Page 4 of 21. Open to participants first (286), then studies with results posted, then the rest; newest registration first within each.

• Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10CompletedNCT04912297Results posted
• Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese AdultsCompletedNCT04882085Phase 4Results posted
• Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.CompletedNCT04878055Phase 3Results posted
• A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)CompletedNCT04830800Phase 1Results posted
• Reparixin in COVID-19 Pneumonia - Efficacy and SafetyTerminatedNCT04794803Phase 2/3Results posted
• Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial PneumoniaCompletedNCT04779242Phase 3Results posted
• Pediatric Helmet CPAP Pilot StudyTerminatedNCT04764929Not applicableResults posted
• Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19CompletedNCT04724538Phase 1/2Results posted
• Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell TransplantationTerminatedNCT04673175Phase 4Results posted
• A Study of Auxora in Patients With Critical COVID-19 PneumoniaTerminatedNCT04661540Phase 2Results posted
• PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and OlderCompletedNCT04613375Results posted
• Treat COVID-19 Patients With RegadenosonCompletedNCT04606069Phase 1/2Results posted
• GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)CompletedNCT04590547Phase 2Results posted
• OPEP Devices in Acute Inpatient Treatment of PneumoniaTerminatedNCT04540510Not applicableResults posted
• Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammationCompletedNCT04492514Phase 2Results posted
• Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.CompletedNCT04491240Phase 1/2Results posted
• Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)CompletedNCT04487886Phase 2Results posted
• Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammationCompletedNCT04463004Phase 2Results posted
• Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE)CompletedNCT04448756Phase 2Results posted
• Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammationCompletedNCT04447469Phase 2/3Results posted
• Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDSCompletedNCT04429555Phase 2Results posted
• Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19CompletedNCT04425863Results posted
• A Study of Opaganib in Coronavirus Disease 2019 PneumoniaCompletedNCT04414618Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19CompletedNCT04412668Phase 2Results posted
• Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung InjuryCompletedNCT04412057Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 PneumoniaCompletedNCT04409262Phase 3Results posted
• TD-0903 for ALI Associated With COVID-19CompletedNCT04402866Phase 2Results posted
• Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammationCompletedNCT04399980Phase 2Results posted
• COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.CompletedNCT04397757Phase 1Results posted
• A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 PneumoniaCompletedNCT04386616Phase 2Results posted
• Study of Efficacy and Safety of MAS825 in Patients With COVID-19CompletedNCT04382651Phase 2Results posted
• Study of Efficacy and Safety of DV890 in Patients With COVID-19 PneumoniaCompletedNCT04382053Phase 2Results posted
• Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.TerminatedNCT04381494Phase 4Results posted
• Convalescent Plasma for Treatment of COVID-19 Patients With PneumoniaCompletedNCT04374565Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 PneumoniaCompletedNCT04372186Phase 3Results posted
• Tocilizumab for Patients With Cancer and COVID-19 DiseaseTerminatedNCT04370834Phase 2Results posted
• Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe PneumoniaTerminatedNCT04369469Phase 3Results posted
• Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19TerminatedNCT04365101Phase 1/2Results posted
• A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 PneumoniaCompletedNCT04363736Phase 2Results posted
• Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced PneumoniaCompletedNCT04362813Phase 3Results posted
• Rhu-pGSN for Severe Covid-19 PneumoniaCompletedNCT04358406Phase 2Results posted
• A Study of Auxora in Patients With Severe COVID-19 PneumoniaCompletedNCT04345614Phase 2Results posted
• A Study of LY3127804 in Participants With COVID-19TerminatedNCT04342897Phase 2Results posted
• Sirolimus Treatment in Hospitalized Patients With COVID-19 PneumoniaCompletedNCT04341675Phase 2Results posted
• Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 PneumoniaCompletedNCT04333420Phase 2/3Results posted
• Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 PneumonitisCompletedNCT04331795Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 PneumoniaCompletedNCT04320615Phase 3Results posted
• Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple CountriesCompletedNCT04198571Results posted
• ARrest RESpiraTory Failure From PNEUMONIATerminatedNCT04193878Phase 3Results posted
• Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial PneumoniaCompletedNCT04160260Phase 1Results posted
• Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial PneumoniaTerminatedNCT04040621Phase 1Results posted
• Exhaled Breath Analysis to Predict Risk of Symptomatic PneumonitisTerminatedNCT04040244Not applicableResults posted
• Avoiding Neuromuscular Blockers to Reduce ComplicationsTerminatedNCT03962725Phase 4Results posted
• Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus ComplexCompletedNCT03894046Phase 3Results posted
• Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial PneumoniaTerminatedNCT03862040Phase 1Results posted
• Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With PneumoniaCompletedNCT03852537Phase 2Results posted
• Improving CarE for Community Acquired Pneumonia 1CompletedNCT03760419Not applicableResults posted
• Endotracheal Tubes to Prevent Ventilator-Associated PneumoniaCompletedNCT03705286Phase 2Results posted
• The INSPIRE-ASP PNA TrialCompletedNCT03697070Not applicableResults posted
• Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)CompletedNCT03583333Phase 3Results posted
• Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired PneumoniaCompletedNCT03551210Phase 3Results posted
• Effect of Angulus on Patient-elevation ComplianceCompletedNCT03496220Not applicableResults posted
• Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer PatientsCompletedNCT03469271Phase 4Results posted
• A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAPCompletedNCT03466073Phase 1/2Results posted
• Ceftobiprole in the Treatment of Pediatric Patients With PneumoniaCompletedNCT03439124Phase 3Results posted
• Implementing a Combination of Clinical Parameters, Biomarkers and SoCs for the Etiology Diagnoses of Pneumonia in Pediatric PatientsCompletedNCT03366454Results posted
• A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.CompletedNCT03329092Phase 3Results posted
• Cx611-0204 SEPCELL StudyCompletedNCT03158727Phase 1/2Results posted
• Genomics and Epigenomics of the Elderly Response to Pneumococcal VaccinesCompletedNCT03104075Phase 4Results posted
• Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative PathogensCompletedNCT03032380Phase 3Results posted
• Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa PneumoniaCompletedNCT03027609Phase 2Results posted
• Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity PneumonitisTerminatedNCT02958917Phase 2Results posted
• Diagnostic Use of Lung Ultrasound for Suspected Pneumonia in NepalCompletedNCT02949141Not applicableResults posted
• Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.TerminatedNCT02940626Phase 2Results posted
• Phase II Study of Oral Nafithromycin in CABPCompletedNCT02903836Phase 2Results posted
• Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in ChildrenCompletedNCT02891915Phase 4Results posted
• Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With PneumoniaCompletedNCT02813694Phase 3Results posted
• Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative PathogensCompletedNCT02714595Phase 3Results posted
• Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated SubjectsCompletedNCT02696902Phase 2Results posted
• Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial PneumoniaCompletedNCT02679573Phase 3Results posted
• Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever)TerminatedNCT02663674Phase 4Results posted
• Stop Exogenous Allergic Alveolitis (EAA) in ChildhoodTerminatedNCT02631603Phase 2Results posted
• Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial PneumoniaTerminatedNCT02605122Phase 2/3Results posted
• Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With PneumoniaCompletedNCT02559310Phase 3Results posted
• A Study of a Vaccine for Pneumonia in Adults and Toddlers in KenyaCompletedNCT02543892Phase 1/2Results posted
• Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)CompletedNCT02531438Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation PneumonitisCompletedNCT02496585Phase 2Results posted
• Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)CompletedNCT02493764Phase 3Results posted
• Aerosolized Antibiotics in the Treatment of Ventilator Associated PneumoniaTerminatedNCT02478710Phase 4Results posted
• Stress Ulcer Prophylaxis in the Intensive Care UnitCompletedNCT02467621Phase 4Results posted
• The Place of Imaging and Microbiology in the Diagnosis of Pneumonia in the ElderlyCompletedNCT02467192Not applicableResults posted
• Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation TherapyTerminatedNCT02452463Phase 2Results posted
• Plasma Pharmacokinetics (PK) & Lung Penetration of Ceftolozane/Tazobactam in Participants With Pneumonia (MK-7625A-007)CompletedNCT02387372Phase 1Results posted
• Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy AdultsCompletedNCT02255760Phase 1Results posted
• Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in AdultsCompletedNCT02168946Phase 3Results posted
• Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese ChildrenCompletedNCT02139228Phase 3Results posted
• Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)TerminatedNCT02138825Phase 2Results posted
• Efficacy Study on Silver-coated ETT Cleaned With a Novel DeviceCompletedNCT02120001Not applicableResults posted
• Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and ToddlersCompletedNCT02097472Phase 1/2Results posted
• Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)CompletedNCT02070757Phase 3Results posted

← Pneumonia overview